Shopping Cart
- Remove All
Your shopping cart is currently empty
Eslicarbazepine (Stedesa) can be used for adjunctive therapy for adults with partial-onset seizures.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $40 | In Stock | |
| 10 mg | $64 | In Stock | |
| 25 mg | $123 | In Stock | |
| 50 mg | $189 | In Stock | |
| 100 mg | $289 | In Stock | |
| 200 mg | $428 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $44 | In Stock |
| Description | Eslicarbazepine (Stedesa) can be used for adjunctive therapy for adults with partial-onset seizures. |
| In vitro | Eslicarbazepine is an anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. Eslicarbazepine acetate is a prodrug for eslicarbazepine (S-licarbazepine), which is a dual Inhibitor of β-Secretase and voltage-gated sodium channel[1][2]. |
| Synonyms | Stedesa, Pazzul, Erelib, EC 810-248-9, BIA 2-194 |
| Molecular Weight | 254.28 |
| Formula | C15H14N2O2 |
| Cas No. | 104746-04-5 |
| Smiles | NC(=O)N1c2ccccc2C[C@H](O)c2ccccc12 |
| Relative Density. | 1.336 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 12 mg/mL (47.19 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.